5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.13▲ | 2.13▲ | 2.13▲ | 2.10▲ | 1.99▲ |
MA10 | 2.13▼ | 2.13▲ | 2.14▼ | 1.99▲ | 2.01▲ |
MA20 | 2.13▲ | 2.14▼ | 2.15▼ | 1.99▲ | 1.99▲ |
MA50 | 2.13▲ | 2.13▲ | 2.06▲ | 1.97▲ | 10.85▼ |
MA100 | 2.14▼ | 2.04▲ | 1.96▲ | 2.02▲ | 15.61▼ |
MA200 | 2.15▼ | 1.97▲ | 2.04▲ | 7.89▼ | 24.50▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.003▼ | -0.011▼ | 0.026▲ | 0.651▲ |
RSI | 51.153▲ | 49.288▼ | 55.097▲ | 57.581▲ | 35.455▼ |
STOCH | 50.000 | 34.722 | 15.643▼ | 82.357▲ | 65.992 |
WILL %R | -33.333 | -75.000▼ | -84.211▼ | -20.833▲ | -15.880▲ |
CCI | 10.606 | -31.573 | -66.667 | 113.104▲ | 62.413 |
CDL | $SAVA Harami Candlestick Pattern Detected | Set Alert |
Wednesday, July 09, 2025 11:13 AM
View the most recent data and latest information on option chains for Cassava Sciences, Inc. Common Stock (SAVA) at Nasdaq.com.
|
Tuesday, March 18, 2025 01:47 AM
Cassava Sciences, Inc. (NASDAQ:SAVA) has faced significant losses, plunging 86.52% over the past year, mainly reflecting challenges within the biotech sector.
|
Friday, March 07, 2025 09:00 AM
Cassava Sciences (SAVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 2.15 | 2.18 | 2.11 | 2.13 | 393,100 |
10/07/25 | 2.18 | 2.21 | 2.13 | 2.16 | 621,027 |
09/07/25 | 2.10 | 2.23 | 2.09 | 2.19 | 1,135,300 |
08/07/25 | 1.94 | 2.11 | 1.94 | 2.08 | 1,013,600 |
07/07/25 | 2.00 | 2.0294 | 1.91 | 1.93 | 740,473 |
03/07/25 | 2.02 | 2.05 | 1.99 | 2.01 | 463,534 |
02/07/25 | 1.86 | 2.04 | 1.86 | 2.01 | 1,291,400 |
01/07/25 | 1.80 | 1.90 | 1.76 | 1.85 | 1,240,600 |
30/06/25 | 1.81 | 1.90 | 1.80 | 1.81 | 1,067,073 |
27/06/25 | 1.84 | 1.85 | 1.75 | 1.75 | 5,991,400 |
|
|
||||
|
|
||||
|
|